Abstract
A third Intercity Meeting under the auspices of the European School of Oncology was held in Barcelona on 27th May, 1988. The subject of the meeting was the current management of non-Hodgkin’s lymphoma (NHL) and the results of the discussion are reported in this paper.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Portlock CS: “Good risk” non-Hodgkin’s lymphomas: approaches to management. Sem Hematol 1983 (20): 25–34
Kinsella TJ: Role of combined-modality therapy in the curative management of advanced-stage “favorable” non-Hodgkin’s lymphomas. Cancer Treat Rep 1982 (66):421–426
Montserrat E, Gardella S, Llebaria C, Rozman C: Deferral of initial therapy in advanced “favorable” lymphomas. In: Sotto JJ et al (eds) Non-Hodgkin’s Lymphomas: New Techniques and Treatments. Karger, Basle 1985 pp 215–220
De Vita VT Jr, Longo DL, Hubbard SM, Young RC, Chabner BA: The lymphomas: biologic implications of therapy and therapeutic implications of the new biology. In: Malignant Lymphoma. Williams & Wilkins, Baltimore 1987 pp 249–267
Giralt M, Montserrat E, Maldonado J et al: Terapéutica de los limfomas no hodgkinianos clínicamente agresivos en estadios III y IV con CHOP. Neoplasia 1986 (3):119–124
Young RC, Longo DL, Glatstein E, Ihde DC, Jaffe ES and De Vita VT Jr: The treatment of indolent lymphomas: watchful and waiting vs aggressive combined modality treatment. Sem Hematol Vol 25, No 2, suppl 2 1988pp 11–16
Lee R, Cabanillas F, Bodey GP, Freireich EJ: A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma. J Clin Oncol 1986 (4): 1455–1461
McLaughlin P, Fuller LM, Velasquez WS et al: Stage III follicular lymphoma: durable remissions with a combined chemotherapy-radiotherapy regimen. J Clin Oncol 1987 (5):867–874
Miller ThP, Dana BW, Weick JK et al: Southwest Oncology Group Clinical Trials for intermediate and high grade non-Hodgkin’s lymphomas. Sem Hematol Vol 25 No 2 suppl 2 pp 1988 17–22
Programa para el estudio y el tratamiento de las hemopatias malignas (PETHEMA). Protocolo XXI, linfomas no Hodgkin, CHOP-ProMACE CytaBOM
Philip T, Armitage JO, Spitzer G et al: High-dose therapy and autologous bohe marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma. N Engl J Med 1987 (316):1493–1498
Takvorian T, Canellos GP, Ritz J et al: Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin’slymphoma with a poor prognosis. N Engl J Med 1987 (316):1499–1505
Anderson JR, Wilson JF, Jenkin DT et al: Childhood non-Hodgkin’s lymphomas: results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) to a 10-drug regimen (LSA2 L2). N Engl J Med 1983 (308):559
Duque-Hammershaimb L, Wollner N, Miller DR: LSA2-L2 protocol treatment of stage IV non-Hodgkin’s lymphoma in children with partial and extensive bone marrow involvement. Cancer 1983 (52):39
Slater DE, Mertelsmann R, Koziner B et al: Lymphoblastic lymphoma in adults. J Clin Oncol 1986(4):57
Philip T, Armitage JO, Spitzer G et al: High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin’s lymphoma. New Engl J Med 1987 (316):1493
Nademanee AP, Foreman JJ, Schmidt GM et al: Allogenic bone marrow transplantation for high risk non-Hodgkin’s lymphoma during first complete remission. Blut 1987 (55):11
Magrath I, Lee YJ, Anderson T et al: Prognostic factors in Burkitt’s lymphoma: importance of total tumor burden. Cancer 1980 (45):1507
Ziegler JL: Burkitt’s lymphoma. New Engl J Med 1981 (305):735
Coiffier B, Bosly A, Galligaris-Cappio F et al, European School of Oncology: Management of non-Hodgkin’s lymphomas: conclusions of the European School of Oncology meeting, 1986. Eur J Cancer Clin Oncol 1987 (23):1691 –1695
Cabanillas F, Hagemeister FB, Riggs S et al: Results of iphosphamide-etoposide combinations for patients with recurrent or refractory aggressive lymphoma. In: Cavalli F, Bonadonna G, Rozencweig M (eds) Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances. 1985 p 485
Lennert T, Mohori M, Stein H: The histopathology of malignant lymphoma. Br J Haematol 1975 (31 suppl):193–203
Zinzani PL, Gherlinzoni F, Lauria F et al: Intensive chemotherapy regimen in high-grade non-Hodgkin’s lymphomas. Tumori 1987 (73):121–126
Tura S, Mazza P, Gherlinzoni F et al: High-dose therapy followed by autologous bone marrow transplantation (ABMT) in previously untreated non-Hodgkin’s lymphomas. Scand J Haematol 1986 (37):347–352
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Estapé, J. et al. (1990). Management of Non-Hodgkin’s Lymphomas: Conclusions of the Third Intercity Meeting, 1988. In: Monfardini, S. (eds) The Management of Non-Hodgkin’s Lymphomas in Europe. ESO Intercity Report. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75528-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-75528-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52297-3
Online ISBN: 978-3-642-75528-6
eBook Packages: Springer Book Archive